These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3296633)

  • 1. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Norrby E
    Acta Paediatr Scand Suppl; 1986; 325():116-24. PubMed ID: 3296633
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypophyseal growth hormone and Creutzfeldt-Jakob disease in The Netherlands. Ad hoc Commission Creutzfeldt-Jakob-disease of the Dutch Growth Foundation].
    Rikken B; Massa GG; Wit JM; van den Brande JL
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1163-5. PubMed ID: 8692348
    [No Abstract]   [Full Text] [Related]  

  • 3. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
    Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
    Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
    Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
    Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New variant Creutzfeldt-Jakob disease and bovine pituitary growth hormone.
    Verdrager J
    Lancet; 1998 Jan; 351(9096):112-3. PubMed ID: 9439502
    [No Abstract]   [Full Text] [Related]  

  • 6. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease.
    Brown P; Preece MA; Will RG
    Lancet; 1992 Jul; 340(8810):24-7. PubMed ID: 1351607
    [No Abstract]   [Full Text] [Related]  

  • 7. The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy.
    Brown P
    Neurology; 1988 Jul; 38(7):1135-7. PubMed ID: 3290705
    [No Abstract]   [Full Text] [Related]  

  • 8. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.
    Marzewski DJ; Towfighi J; Harrington MG; Merril CR; Brown P
    Neurology; 1988 Jul; 38(7):1131-3. PubMed ID: 3290703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic transmission of Creutzfeldt-Jakob disease.
    Weller RO
    Psychol Med; 1989 Feb; 19(1):1-4. PubMed ID: 2657828
    [No Abstract]   [Full Text] [Related]  

  • 10. Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient.
    New MI; Brown P; Temeck JW; Owens C; Hedley-Whyte ET; Richardson EP
    Neurology; 1988 Jul; 38(7):1133-4. PubMed ID: 3290704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications.
    Tintner R; Brown P; Hedley-Whyte ET; Rappaport EB; Piccardo CP; Gajdusek DC
    Neurology; 1986 Jul; 36(7):932-6. PubMed ID: 3520381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease: search for a genetic susceptibility by analysis of the PRNP coding region.
    Jaegly A; Boussin F; Deslys JP; Dormont D
    Genomics; 1995 May; 27(2):382-3. PubMed ID: 7558015
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatrogenic cases.
    Brown P
    Ciba Found Symp; 1988; 135():3-23. PubMed ID: 3044708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iatrogenic Creutzfeldt-Jakob disease. Lessons from cases secondary to extracted growth hormone in France].
    Billette de Villemeur T; Pradel A
    Transfus Clin Biol; 1994; 1(5):333-7. PubMed ID: 7812459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of Creutzfeldt-Jakob disease associated with the use of human pituitary growth hormone.
    Will RG
    Dev Biol Stand; 1991; 75():85-6. PubMed ID: 1794632
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical review 58: Creutzfeldt-Jakob disease in recipients of pituitary hormones.
    Frasier SD; Foley TP
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1277-9. PubMed ID: 8200924
    [No Abstract]   [Full Text] [Related]  

  • 17. Human pituitary growth hormone (hGH) and Creutzfeldt-Jakob disease: results of an epidemiological survey in France, 1986.
    Goujard J; Entat M; Maillard F; Mugnier E; Rappaport R; Job JC
    Int J Epidemiol; 1988 Jun; 17(2):423-7. PubMed ID: 3042652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degenerative neurologic disease in patients formerly treated with human growth hormone. Report of the Committee on Growth Hormone Use of the Lawson Wilkins Pediatric Endocrine Society, May 1985.
    J Pediatr; 1985 Jul; 107(1):10-2. PubMed ID: 3891943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pituitary growth hormone and Creutzfeldt-Jakob disease.
    Preece M
    Horm Res; 1993; 39(3-4):95-8. PubMed ID: 8262483
    [No Abstract]   [Full Text] [Related]  

  • 20. Human growth hormone and Creutzfeldt-Jakob disease.
    Raiti S
    Ann Intern Med; 1985 Aug; 103(2):288-9. PubMed ID: 3893258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.